Transaction DateRecipientSharesTypePriceValue
6th January 2021Capital, Llc Armistice0Open or private purchase$0.00
6th January 2021Capital, Llc Armistice1,531,101Open or private purchase$5.23$8,000,002.73
11th December 2020Abraham N. Oler30,000Open or private purchase$0.32$9,600.00
4th December 2020Capital, Llc Armistice0Open or private purchase$0.00
4th December 2020Capital, Llc Armistice5,400Open or private purchase$4.13$22,302.00
3rd December 2020Capital, Llc Armistice0Open or private purchase$0.00
3rd December 2020Capital, Llc Armistice20,000Open or private purchase$2.44$48,800.00
2nd December 2020Capital, Llc Armistice0Open or private purchase$0.00
2nd December 2020Capital, Llc Armistice1,000Open or private purchase$4.31$4,310.00
27th November 2020Mark Patrick Guerin4,614Open or private purchase$0.26$1,199.64
Onconova Therapeutics
Onconova Therapeutics logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.


Onconova Therapeutics, Inc. focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy in 1998.


Ticker: ONTX
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1130598
Employees: 19
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals